207 related articles for article (PubMed ID: 19774418)
1. Initial presentation and management of hilar and peripheral cholangiocarcinoma: is a node-positive status or potential margin-positive result a contraindication to resection?
Nguyen KT; Steel J; Vanounou T; Tsung A; Marsh JW; Geller DA; Gamblin TC
Ann Surg Oncol; 2009 Dec; 16(12):3308-15. PubMed ID: 19774418
[TBL] [Abstract][Full Text] [Related]
2. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
de Jong MC; Marques H; Clary BM; Bauer TW; Marsh JW; Ribero D; Majno P; Hatzaras I; Walters DM; Barbas AS; Mega R; Schulick RD; Choti MA; Geller DA; Barroso E; Mentha G; Capussotti L; Pawlik TM
Cancer; 2012 Oct; 118(19):4737-47. PubMed ID: 22415526
[TBL] [Abstract][Full Text] [Related]
3. Surgery for hilar cholangiocarcinoma: the Leeds experience.
Hidalgo E; Asthana S; Nishio H; Wyatt J; Toogood GJ; Prasad KR; Lodge JP
Eur J Surg Oncol; 2008 Jul; 34(7):787-94. PubMed ID: 18036765
[TBL] [Abstract][Full Text] [Related]
4. Aggressive surgical resection for hilar-invasive and peripheral intrahepatic cholangiocarcinoma.
Nakagohri T; Asano T; Kinoshita H; Kenmochi T; Urashima T; Miura F; Ochiai T
World J Surg; 2003 Mar; 27(3):289-93. PubMed ID: 12607053
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic, peri-hilar and distal cholangiocarcinoma: Three different locations of the same tumor or three different tumors?
Ercolani G; Dazzi A; Giovinazzo F; Ruzzenente A; Bassi C; Guglielmi A; Scarpa A; D'Errico A; Pinna AD
Eur J Surg Oncol; 2015 Sep; 41(9):1162-9. PubMed ID: 26095704
[TBL] [Abstract][Full Text] [Related]
6. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival.
Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB
Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372
[TBL] [Abstract][Full Text] [Related]
7. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
[TBL] [Abstract][Full Text] [Related]
8. Portal vein resection for hilar cholangiocarcinoma.
Hemming AW; Kim RD; Mekeel KL; Fujita S; Reed AI; Foley DP; Howard RJ
Am Surg; 2006 Jul; 72(7):599-604; discussion 604-5. PubMed ID: 16875081
[TBL] [Abstract][Full Text] [Related]
9. Oncological superiority of hilar en bloc resection for the treatment of hilar cholangiocarcinoma.
Neuhaus P; Thelen A; Jonas S; Puhl G; Denecke T; Veltzke-Schlieker W; Seehofer D
Ann Surg Oncol; 2012 May; 19(5):1602-8. PubMed ID: 21964888
[TBL] [Abstract][Full Text] [Related]
10. Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases.
Ebata T; Nagino M; Kamiya J; Uesaka K; Nagasaka T; Nimura Y
Ann Surg; 2003 Nov; 238(5):720-7. PubMed ID: 14578735
[TBL] [Abstract][Full Text] [Related]
11. Surgical treatment of hilar cholangiocarcinoma in the new era: the Asan experience.
Lee SG; Song GW; Hwang S; Ha TY; Moon DB; Jung DH; Kim KH; Ahn CS; Kim MH; Lee SK; Sung KB; Ko GY
J Hepatobiliary Pancreat Sci; 2010 Jul; 17(4):476-89. PubMed ID: 19851704
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?
Lu J; Li B; Li FY; Ye H; Xiong XZ; Cheng NS
Eur J Surg Oncol; 2019 Nov; 45(11):2173-2179. PubMed ID: 31208772
[TBL] [Abstract][Full Text] [Related]
13. [Biopathological characteristics of hilar cholangiocarcinoma and the clinical significance].
Yu WL; Zhang YJ; Dong H; Yu H; Xian ZH; Wu MC; Cong WM
Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1162-6. PubMed ID: 20021908
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma.
Murakami Y; Uemura K; Sudo T; Hashimoto Y; Nakashima A; Kondo N; Sakabe R; Ohge H; Sueda T
Ann Surg Oncol; 2011 Mar; 18(3):651-8. PubMed ID: 20945107
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome after resection of early-stage hilar cholangiocarcinoma.
Stremitzer S; Jones RP; Quinn LM; Fenwick SW; Diaz-Nieto R; Poston GJ; Malik HZ
Eur J Surg Oncol; 2019 Feb; 45(2):213-217. PubMed ID: 30360988
[TBL] [Abstract][Full Text] [Related]
16. Impact of specialized multi-disciplinary approach and an integrated pathway on outcomes in hilar cholangiocarcinoma.
Gomez D; Patel PB; Lacasia-Purroy C; Byrne C; Sturgess RP; Palmer D; Fenwick S; Poston GJ; Malik HZ
Eur J Surg Oncol; 2014 Jan; 40(1):77-84. PubMed ID: 24262111
[TBL] [Abstract][Full Text] [Related]
17. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma.
Jarnagin WR; Fong Y; DeMatteo RP; Gonen M; Burke EC; Bodniewicz BS J; Youssef BA M; Klimstra D; Blumgart LH
Ann Surg; 2001 Oct; 234(4):507-17; discussion 517-9. PubMed ID: 11573044
[TBL] [Abstract][Full Text] [Related]
18. Surgical treatment of mass-forming intrahepatic cholangiocarcinoma: an 11-year Western single-center experience in 107 patients.
Yedibela S; Demir R; Zhang W; Meyer T; Hohenberger W; Schönleben F
Ann Surg Oncol; 2009 Feb; 16(2):404-12. PubMed ID: 19037702
[TBL] [Abstract][Full Text] [Related]
19. Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the UK.
Silva MA; Tekin K; Aytekin F; Bramhall SR; Buckels JA; Mirza DF
Eur J Surg Oncol; 2005 Jun; 31(5):533-9. PubMed ID: 15922889
[TBL] [Abstract][Full Text] [Related]
20. Surgical management of hilar bile duct cancer. Preoperative diagnosis, selection of treatment options and clinical outcome.
Hirai I; Kimura W; Fuse A; Suto K; Sakurai F; Ishiyama S
Hepatogastroenterology; 2003; 50(51):629-35. PubMed ID: 12828048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
